Vijaya Diagnostic Centre Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.160x

Vijaya Diagnostic Centre Limited cash flow conversion efficiency. Based on the latest financial reports, Vijaya Diagnostic Centre Limited (VIJAYA) has a cash flow conversion efficiency ratio of 0.160x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.39 Billion ≈ $14.99 Million USD) by net assets (Rs8.65 Billion ≈ $93.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Vijaya Diagnostic Centre Limited (2019–2026)

Cash flow conversion efficiency of Vijaya Diagnostic Centre Limited from 2019 to 2026. This chart illustrates how Vijaya Diagnostic Centre Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Vijaya Diagnostic Centre Limited for real-time trading data and today's change.

Vijaya Diagnostic Centre Limited Cash Flow Conversion Ratio Explained

Vijaya Diagnostic Centre Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Vijaya Diagnostic Centre Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vijaya Diagnostic Centre Limited ranked by their cash flow conversion efficiency. Also see Vijaya Diagnostic Centre Limited (VIJAYA) market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
AlzChem Group AG
XETRA:ACT
0.048x
Costamare Inc
NYSE:CMRE
0.044x
Nextnav Acquisition Corp
NASDAQ:NN
-0.054x
Hamburger Hafen und Logistik Aktiengesellschaft
F:HHFA
0.069x
Live Oak Bancshares, Inc.
NYSE:LOB
0.090x
Pimco Dynamic Income Opportunities Fund
NYSE:PDO
0.276x
Chongqing Three Gorges Water Conservancy and Electric Power Co Ltd
SHG:600116
0.048x
BlueNord ASA
OL:BNOR
0.533x

Annual Cash Flow Conversion Efficiency for Vijaya Diagnostic Centre Limited (2019–2026)

The table below shows the annual cash flow conversion efficiency of Vijaya Diagnostic Centre Limited from 2019 to 2026. Review VIJAYA free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs9.57 Billion
≈ $103.51 Million
Rs2.71 Billion
≈ $29.26 Million
0.283x +0.65%
2025-03-31 Rs7.99 Billion
≈ $86.42 Million
Rs2.24 Billion
≈ $24.28 Million
0.281x +1.13%
2024-03-31 Rs6.60 Billion
≈ $71.37 Million
Rs1.83 Billion
≈ $19.82 Million
0.278x -7.76%
2023-03-31 Rs5.47 Billion
≈ $59.12 Million
Rs1.65 Billion
≈ $17.80 Million
0.301x -10.51%
2022-03-31 Rs4.70 Billion
≈ $50.78 Million
Rs1.58 Billion
≈ $17.09 Million
0.336x -6.76%
2021-03-31 Rs3.59 Billion
≈ $38.85 Million
Rs1.30 Billion
≈ $14.02 Million
0.361x -6.76%
2020-03-31 Rs2.74 Billion
≈ $29.65 Million
Rs1.06 Billion
≈ $11.48 Million
0.387x -11.49%
2019-03-31 Rs2.07 Billion
≈ $22.39 Million
Rs905.27 Million
≈ $9.79 Million
0.437x --

About Vijaya Diagnostic Centre Limited

NSE:VIJAYA India Diagnostics & Research
Market Cap
$1.62 Billion
Rs150.11 Billion INR
Market Cap Rank
#6676 Global
#307 in India
Share Price
Rs1457.40
Change (1 day)
+0.81%
52-Week Range
Rs861.40 - Rs1570.70
All Time High
Rs1570.70
About

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T ser… Read more